Close

Entera Bio (ENTX) Climbs 65% Pre-Open Following EB613 Phase 2 Biomarker Data

March 12, 2021 6:57 AM EST Send to a Friend
Entera Bio Ltd. (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login